MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases
Die Pharmazie · 2026
DOI: 10.31083/pharmazie51802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Die Pharmazie, 2026. Verfasst von Jiajia Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Marine Biological Resources and Environment, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of …. Hauptthemen laut MEDLINE: Cachexia, Receptor, Melanocortin, Type 4. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Melanocortin-4 receptor (MC4R) is a key receptor in the hypothalamus regulating appetite and energy metabolism. Research has indicated that MC4R agonists have demonstrated potential for weight loss; its antagonists may stimulate appetite and weight gain, showing potential therapeutic applications in patients with anorexia or cachexia or those requiring weight restoration. However, the signaling mechanism, clinical applications, and safety profile of MC4R antagonists still require in-depth investigation. The purpose of this review is to comprehensively summarize the research progress of MC4R antagonists, analyze their mechanism of action and clinical applications, evaluate their safety profile, and explore future research directions. Future studies should focus on developing safer and more effective MC4R antagonists and exploring the therapeutic potential of MC4R in other diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Marine Biological Resources and Environment, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of Pharmacy, Jiangsu Ocean University, 222005 Lianyungang, Jiangsu, China.
- Medicine Center, Guangxi University of Science and Technology, 545006 Liuzhou, Guangxi, China.
- Grand Medical Nutrition Science (Wuhan) Co., LTD., 430040 Wuhan, Hubei, China.
Zitieren
APA
Shi, J., Xiong, J., Hao, C., Huang, L., & Chen, Y. (2026). MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases. Die Pharmazie. https://doi.org/10.31083/pharmazie51802
Vancouver
Shi J, Xiong J, Hao C, Huang L, Chen Y. MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases. Die Pharmazie. 2026. doi:10.31083/pharmazie51802
BibTeX
@article{Shi2026,
author = {Shi, Jiajia and Xiong, Jiaying and Hao, Chao and Huang, Ling and Chen, Yin},
title = {MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases},
journal = {Die Pharmazie},
year = {2026},
doi = {10.31083/pharmazie51802}
}
EUVIMED